Preview
  • For Blood and Money

  • Billionaires, Biotech, and the Quest for a Blockbuster Drug
  • By: Nathan Vardi
  • Narrated by: Rob Shapiro
  • Length: 8 hrs and 33 mins
  • 4.7 out of 5 stars (216 ratings)

Prime logo Prime members: New to Audible?
Get 2 free audiobooks during trial.
Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 30 days. Cancel anytime.

For Blood and Money

By: Nathan Vardi
Narrated by: Rob Shapiro
Try for $0.00

$14.95/month after 30 days. Cancel anytime.

Buy for $29.95

Buy for $29.95

Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.

Publisher's summary

A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market—and save countless lives.

For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.

In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks—and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they’re onto something big.

What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi’s narrative immerses listeners in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction listen, For Blood and Money illustrates why it’s so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine.

©2023 Nathan Vardi (P)2023 Audible, Inc.
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about For Blood and Money

Average customer ratings
Overall
  • 4.5 out of 5 stars
  • 5 Stars
    167
  • 4 Stars
    30
  • 3 Stars
    13
  • 2 Stars
    5
  • 1 Stars
    1
Performance
  • 4.5 out of 5 stars
  • 5 Stars
    146
  • 4 Stars
    25
  • 3 Stars
    8
  • 2 Stars
    1
  • 1 Stars
    1
Story
  • 5 out of 5 stars
  • 5 Stars
    150
  • 4 Stars
    21
  • 3 Stars
    5
  • 2 Stars
    3
  • 1 Stars
    1

Reviews - Please select the tabs below to change the source of reviews.

Sort by:
Filter by:
  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Entertaining and informative

I really enjoyed the book. Educational about cancer and tech investing. We’ll performed as well.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Really enjoyed this title

A great story at the intersection of cutting edge medical science, high -stakes finance, and human personalities and foibles. I found it fascinating to get an inside view on the development of new drugs, whose failures often exceed their promise, while many others sit on shelves waiting for often serendipitous discovery by financiers and corporations.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

1 person found this helpful

  • Overall
    5 out of 5 stars
  • Performance
    3 out of 5 stars
  • Story
    5 out of 5 stars

Interesting story hampered by incorrect pronunciation

As a hematologist the story of the real world of venture capitalism in the production of this outstanding drug was interesting and disturbing. The docs doing the real work were cast aside because of finance kings- very unfair. The story was hampered by incorrect pronunciation of specific scientific terms (such as the initial mentions of tyrosine kinases and the organization ASH) which would have been easily corrected if the narrator (who is good otherwise) did this in the presence of a person in the field.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

the sums of money will blow your mind

it was an important story to tell about modern drug development. it's interesting to hear how hedgefunds and investors make massively expensive drug trials possible sometimes taking huge losses but this time making an enormous windfall.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Fascinating look into the ecosystem and politics of drug development

Vardi gives a detailed account of the harrowing story of the grit and perseverance of scientists and investors as they put everything on the line to bring an elegant molecule in a novel class of class of cancer medicines to patients with little alternative. Amazing testament to what people can achieve when they work together. The money involved is mind boggling and not something that I personally focus on, but it is a clear driver for many involved. Highly recommended.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

a close view of the biotechnology industry

Was riveted by the story of the Ceos and the researchers. I never realized that it is a ruthless field.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Amazing Ride Through the World of Biotech

Really interesting story with lots of twists and turns as the story unfolds of how two blockbuster drugs were delivered to market.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Captivating!

Great storyline and narration! The story started slow but really picked up pace over the chapters!

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    4 out of 5 stars
  • Story
    5 out of 5 stars

Great true and timely story of our broken system

Whatever a page turner is for audio...this is it. I am an insider in the industry, and to me this was as good as any action movie.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Clever and Clear

A great story and view into both the venture world and the science of BTK inhibitors and cancer

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!